Table 1. Baseline Characteristics of the Participants in the Intention-to-Treat Analysisa.
| Characteristic | Dequalinium chloride (n = 72) | Metronidazole (n = 75) | Total (N = 147) |
|---|---|---|---|
| Age, mean (SD), y | 36.0 (9.2) | 37.5 (8.9) | 36.7 (9.0) |
| Ethnicity | |||
| Not Hispanic or Latino | 71 (98.6) | 74 (98.7) | 145 (98.6) |
| Hispanic or Latino | 1 (1.4) | 1 (1.3) | 2 (1.4) |
| White race | 72 (100) | 75 (100) | 147 (100) |
| Nugent score | |||
| Normal | 18 (25.0) | 23 (30.7) | 41 (27.9) |
| Intermediate | 15 (20.8) | 10 (13.3) | 25 (17.0) |
| Bacterial vaginosis | 39 (54.2) | 41 (54.7) | 80 (54.4) |
| Missing score | 0 | 1 (1.3) | 1 (0.7) |
| Gynecologic history, median (IQR) | |||
| No. of pregnancies | 1.5 (0.0-2.0) | 1.0 (0.0-2.0) | 1 (0.0-2.0) |
| No. of vaginal infections in the last 12 mo | 1.0 (0.0-3.0) | 0.0 (0.0-3.0) | 1 (0.0-3.0) |
a
Data are presented as number (percentage) of patients unless otherwise indicated.